MMP9 and type 1 diabetes mellitus: In the present study, hAFSCs treatment after cerebral stroke in T1DM rats significantly reduced the expression of pro‐inflammatory factor (MMP9) and ED‐1 (marker of macrophage) in ischaemic brain.